RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial

Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial

Add to Collection
RCTs HU Häring, L Merker, E Seewaldt-Becker… - Diabetes …, 2013 - Am Diabetes Assoc

Chapter : Section9
Journal Year : 2013
Cited by : 445

… are observed in patients with type 2 diabetes (7), which may … 2 diabetes, in particular without the risk of hypoglycemia and … for the treatment of type 2 diabetes. SGLT2 is responsible for …..... Read More

Keywords : ['randomize doubleblind placebocontrolle trial', 'metformin plus sulfonylurea', 'type diabetes', 'patient', 'empagliflozin', 'addon']
PubMed Link : https://diabetesjournals.org/care/article-abstract/36/11/3396/38116
Google Scholar Link : https://scholar.google.com/scholar?cites=8931555357913199500&as_sdt=2005&sciodt=0,5&hl=en&num=20